These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 7537429

  • 1. Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a program with more than 30000 screened pregnancies.
    Candenas M, Villa R, Fernandez Collar R, Moina MJ, Pintado S, Garcia Saez F, Alvarez FV.
    Acta Obstet Gynecol Scand; 1995 Apr; 74(4):266-9. PubMed ID: 7537429
    [Abstract] [Full Text] [Related]

  • 2. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
    Norem CT, Schoen EJ, Walton DL, Krieger RC, O'Keefe J, To TT, Ray GT.
    Obstet Gynecol; 2005 Oct; 106(4):747-52. PubMed ID: 16199631
    [Abstract] [Full Text] [Related]

  • 3. [Prevalence of neural tube defects in Asturias (Spain): impact of prenatal diagnosis].
    García López E, Rodríguez Dehli C, Ariza Hevia F, Rodríguez Fernández A, Fernández Toral J, Riaño Galán I, Mosquera Tenreiro C.
    Gac Sanit; 2009 Oct; 23(6):506-11. PubMed ID: 19406531
    [Abstract] [Full Text] [Related]

  • 4. Results and benefits of a maternal serum alpha-fetoprotein screening program.
    Milunsky A, Alpert E.
    JAMA; 1984 Sep 21; 252(11):1438-42. PubMed ID: 6206249
    [Abstract] [Full Text] [Related]

  • 5. Early pregnancy screening for neural tube defects in Israel.
    Legum C, Shomrat R, Yedwab G, Jaffa AJ, Rudick A.
    Isr J Med Sci; 1986 Sep 21; 22(3-4):210-4. PubMed ID: 2427475
    [Abstract] [Full Text] [Related]

  • 6. Elevated maternal serum alpha-fetoprotein (MSAFP): interpretation and follow-up.
    Burton BK.
    Clin Obstet Gynecol; 1988 Jun 21; 31(2):293-305. PubMed ID: 2456869
    [Abstract] [Full Text] [Related]

  • 7. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
    Chan A, Robertson EF, Haan EA, Ranieri E, Keane RJ.
    Br J Obstet Gynaecol; 1995 May 21; 102(5):370-6. PubMed ID: 7542023
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
    Milunsky A, Jick SS, Bruell CL, MacLaughlin DS, Tsung YK, Jick H, Rothman KJ, Willett W.
    Am J Obstet Gynecol; 1989 Aug 21; 161(2):291-7. PubMed ID: 2475017
    [Abstract] [Full Text] [Related]

  • 10. Maternal serum alpha fetoprotein among pregnant females in Alexandria.
    Baghagho EE, Kharboush IF, El-Kaffash DM, KarKour TA, Ismail SR, Mortada MM.
    J Egypt Public Health Assoc; 2004 Aug 21; 79(1-2):59-81. PubMed ID: 16916050
    [Abstract] [Full Text] [Related]

  • 11. Prenatal screening for open neural tube defects.
    Canick JA, Kellner LH, Bombard AT.
    Clin Lab Med; 2003 Jun 21; 23(2):385-94, ix. PubMed ID: 12848450
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Twin pregnancies in the second trimester in women in an alpha-fetoprotein screening program: sonographic evaluation and outcome.
    Pretorius DH, Budorick NE, Scioscia AL, Krabbe JK, Ko S, Myhre CM.
    AJR Am J Roentgenol; 1993 Nov 21; 161(5):1007-13. PubMed ID: 7506005
    [Abstract] [Full Text] [Related]

  • 14. Impact of prenatal mid-trimester screening on the prevalence of fetal structural anomalies: a prospective epidemiological study.
    Papp Z, Tóth-Pál E, Papp C, Tóth Z, Szabó M, Veress L, Török O.
    Ultrasound Obstet Gynecol; 1995 Nov 21; 6(5):320-6. PubMed ID: 8590201
    [Abstract] [Full Text] [Related]

  • 15. Maternal serum alpha-fetoprotein screening for the detection of neural tube defects.
    Crandall BF, Robertson RD, Lebherz TB, King W, Schroth PC.
    West J Med; 1983 Apr 21; 138(4):524-30. PubMed ID: 6191442
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Maternal serum alpha-fetoprotein screening: a cost-benefit analysis.
    Layde PM, von Allmen SD, Oakley GP.
    Am J Public Health; 1979 Jun 21; 69(6):566-73. PubMed ID: 87134
    [Abstract] [Full Text] [Related]

  • 18. All MoMs are not equal: some statistical properties associated with reporting results in the form of multiples of the median.
    Bishop JC, Dunstan FD, Nix BJ, Reynolds TM, Swift A.
    Am J Hum Genet; 1993 Feb 21; 52(2):425-30. PubMed ID: 7679245
    [Abstract] [Full Text] [Related]

  • 19. Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center.
    Cariati E, Brizzi L, Periti E.
    J Nucl Med Allied Sci; 1989 Feb 21; 33(3 Suppl):72-6. PubMed ID: 2480428
    [Abstract] [Full Text] [Related]

  • 20. [Screening of pregnant women for fetal neural tube defects by determination of the serum alpha fetoprotein level].
    Los FJ, Hagenaars AM, Huisjes HJ, de Bruyn HW, Ruitenberg EJ.
    Ned Tijdschr Geneeskd; 1980 Jul 05; 124(27):1096-101. PubMed ID: 6157115
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.